Table 1 Clinical characteristics and outcomes of MM patients with SARS-Cov-2 infection.
Patient | Age | Sex | Race | Co-morbidities | Isotype | Phase of treatment | CVOID-19 symptoms | Hospitalization days | ICU admission | HCQ/AZT | Mechanical Ventilation | Survival status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
#1 | 76 | F | AA | HTN | Kappa LC | DRD (early relapse) | Fever, dry cough and SOB | 5 | Yes | Yes | No | Dead |
#2 | 48 | F | Hispanic | None | IgA lambda | Lenalidomide maintenance | Fever, body aches and cough | Not hospitalized | NA | No | No | Symptoms resolved Alive |
#3 | 65 | F | AA | None | IgA kappa | VRD induction | Fever and SOB | Cardiac arrest at home | NA | AZT | No | Dead |
#4 | 77 | F | AA | HTN Heart Failure COPD | Kappa LC | Observation | Fever, dry cough and SOB | 9 | Yes | No** | No | Discharged Alive |
#5 | 82 | M | Caucasian | HTN CAD | IgG kappa | KPD (late relapse) | Fever and fatigue | 6 | No | HCQ | No | Discharged Alive, but died in nursing home after 10 days |
#6 | 75 | M | Caucasian | HTN DM OSA | Kappa LC | Lenalidomide maintenance | Vomiting, diarrhea, dry cough and SOB | 7 | Yes | No | Yes | Dead |
#7 | 50 | F | Caucasian | None | IgA Lambda (SMM) | Observation | Cough and SOB | 5 | Yes | No | No | Alive |
